Cetera Investment Advisers Journey Medical Corp Transaction History
Cetera Investment Advisers
- $49.2 Billion
- Q1 2025
A detailed history of Cetera Investment Advisers transactions in Journey Medical Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 15,149 shares of DERM stock, worth $109,678. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,149
Previous 13,839
9.47%
Holding current value
$109,678
Previous $56,000
58.93%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
5.89MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.4 Million0.71% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT931KShares$6.74 Million0.03% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.26 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA372KShares$2.7 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.338KShares$2.45 Million0.01% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $84M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...